U.S. and Japanese Platelet Rich Plasma Market
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “U.S. and Japan Platelet Rich Plasma Market Size, Share & Trends Analysis Report by Type, (Pure Platelet Rich Plasma, Leukocyte Rich Platelet Rich Plasma), Application, End-use, Country, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The U.S. and Japan platelet rich plasma market size is anticipated to reach USD 348.45 million by 2030, registering a CAGR of 10.15% from 2024 to 2030. The U.S. and Japan platelet rich plasma (PRP) market is driven by increasing incidence of orthopedic disorders and sports injuries, growing number of cosmetic surgeries, and expanding medical application of platelet rich plasma. Moreover, increasing evidence-based studies for platelet rich plasma-based wound healing are further propelling growth of overall the market.
The application of platelet rich plasma products in treatment of musculoskeletal conditions, orthopedic disorders, and sports injuries has become more prevalent over recent years. Several research studies have observed that an increased concentration of growth factors in PRP can potentially accelerate healing process. PRP has proven to be a major source of autologous products in the field and a true precursor for healing process along with stem cells & scaffold. According to U.S. CDC data, participation of individuals in sports in the…
